Lyme disease laboratory diagnostic regulatory update

The Mayo Foundation received U.S. Patent No. 6,045,804 covering a Lyme disease diagnostic that uses OspA deficient antigens from mutant Borrelia burgdorferi. The test, which is exclusively licensed to...